💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Former FrontPoint manager, out of jail, wants to run prison ministry

Published 08/07/2017, 04:50 PM
Updated 08/07/2017, 05:00 PM
© Reuters. FILE PHOTO: Joseph "Chip" Skowron, who ran FrontPoint Partners' healthcare funds, exits the Manhattan Federal Courthouse in New York
MS
-

By Brendan Pierson

(Reuters) - A former manager at defunct hedge fund FrontPoint Partners who served more than three years in prison for insider trading on Monday asked a U.S. judge to end his supervised release early so he can help a run a Christian ministry aimed at prisoners.

In a letter to U.S. District Judge Denise Cote in Manhattan, a lawyer for Joseph "Chip" Skowron said the request was warranted in light of his client's "exemplary" behavior since his April 2011 arrest.

While serving time at Schuylkill Federal Prison Camp in Pennsylvania, Skowron, 48, worked as a tutor, started a Sunday Bible study and led Monday morning religious meetings, according to his lawyer Joshua Epstein.

After serving the last several months of his sentence in home confinement and following his release last November, Skowron co-founded a chapter of the New Canaan Society, a Connecticut-based Christian group, Epstein wrote. The chapter, NCS Inside, is devoted to ministering to federal and state prison inmates.

The NCS website describes itself as a men's-only group who "gather together to encourage each other in friendship and faith."

Epstein said prisons have refused to let Skowron enter to meet with prisoners because he is on supervised release.

"This is limiting Mr. Skowron's efforts on behalf of NCS Inside, as well as NCS Inside's effectiveness and reach," Epstein wrote.

Federal prosecutors are not objecting to Skowron's request, according to Dawn Dearden, a spokeswoman for the U.S. attorney's office in Manhattan.

Skowron pleaded guilty in August 2011 to one count of conspiracy to commit securities fraud and obstruct justice, admitting that he traded in the securities of Human Genome Sciences Inc in 2008 based on non-public information.

In a separate civil case, Skowron was ordered to pay back $31 million of his compensation to Morgan Stanley (NYSE:MS), which owned FrontPoint between 2006 and 2011, minus a $6 million penalty he was already ordered to pay in his criminal case.

© Reuters. FILE PHOTO: Joseph "Chip" Skowron, who ran FrontPoint Partners' healthcare funds, exits the Manhattan Federal Courthouse in New York

Investors began pulling out of FrontPoint in the wake of the insider trading charges, ultimately forcing the firm, which once managed as much as $11 billion, to shut down.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.